Javascript must be enabled to continue!
Editorial
View through CrossRef
From Editor’s Desk…
Twenty million new cases and ten million cancer-related deaths were predicted to occur worldwide. Every year, around 2.7 million people in the European Union are diagnosed with cancer, with this statistic anticipated to climb in the future. Around 40% of cancer cases in the EU are preventable. Safe and effective vaccines are available, and they have the potential to save many lives. A number of governments and firms are developing cancer vaccines.
A global trial of the first personalized mRNA cancer immunotherapy for melanoma has begun at University College London Hospital (UCLH), indicating a significant breakthrough in 2024. Melanoma is the deadliest type of skin cancer. Each year, 8,400 new cases are reported in the United Kingdom. It presently ranks fifth.
Exactly two months ago, the Russian scientists stated that they were close to developing cancer vaccines, which might transform cancer treatment worldwide. While he did not specify which cancers or pathways he was targeting, several countries and companies are already investigating similar treatments.
An investigational treatment technique for pancreatic cancer using the messenger RNA (mRNA)-based therapeutic cancer vaccine candidate autogene cevumeran continues to show promise in eliciting an immune response, potentially lowering the risk of cancer returning after surgery.
According to the World Health Organization, there are currently six licensed vaccines against human papillomaviruses (HPV), which cause a range of cancers, including cervical cancer, as well as vaccines against hepatitis B (HBV), which causes liver cancer.
Furthermore, researchers have obtained critical funding to develop LungVax, which aims to kill cancer cells using a strategy similar to that used to create the AstraZeneca COVID-19 vaccine. CureVac N.V. and the University of Texas MD Anderson Cancer Center established a collaboration to develop and license new mRNA-based cancer vaccines.
Reference:
•https://www.paho.org/en/campaigns/world-cancer-day-2023-close-care gap#:~:text=Globally%2C%20there%20were%20an%20estimated,10%20million%20deaths%20from%20cancer.
•https://www.reuters.com/business/healthcare-pharmaceuticals/putin-says-russia-is-close-creatingcancer-vaccines-2024-02-14/
•https://news.sky.com/story/groundbreaking-lung-cancer-vaccine-being-developed-13099391
•https://www.mskcc.org/news/can-mrna-vaccines-fight-pancreatic-cancer-msk-clinical-researchers-are-trying-find-out
•https://www.nihr.ac.uk/news/trial-begins-for-groundbreaking-new-personalised-melanoma-treatment/35928
Dr. Khalid Mohammed Alabdulwahhab
Editor in Chief
Title: Editorial
Description:
From Editor’s Desk…
Twenty million new cases and ten million cancer-related deaths were predicted to occur worldwide.
Every year, around 2.
7 million people in the European Union are diagnosed with cancer, with this statistic anticipated to climb in the future.
Around 40% of cancer cases in the EU are preventable.
Safe and effective vaccines are available, and they have the potential to save many lives.
A number of governments and firms are developing cancer vaccines.
A global trial of the first personalized mRNA cancer immunotherapy for melanoma has begun at University College London Hospital (UCLH), indicating a significant breakthrough in 2024.
Melanoma is the deadliest type of skin cancer.
Each year, 8,400 new cases are reported in the United Kingdom.
It presently ranks fifth.
Exactly two months ago, the Russian scientists stated that they were close to developing cancer vaccines, which might transform cancer treatment worldwide.
While he did not specify which cancers or pathways he was targeting, several countries and companies are already investigating similar treatments.
An investigational treatment technique for pancreatic cancer using the messenger RNA (mRNA)-based therapeutic cancer vaccine candidate autogene cevumeran continues to show promise in eliciting an immune response, potentially lowering the risk of cancer returning after surgery.
According to the World Health Organization, there are currently six licensed vaccines against human papillomaviruses (HPV), which cause a range of cancers, including cervical cancer, as well as vaccines against hepatitis B (HBV), which causes liver cancer.
Furthermore, researchers have obtained critical funding to develop LungVax, which aims to kill cancer cells using a strategy similar to that used to create the AstraZeneca COVID-19 vaccine.
CureVac N.
V.
and the University of Texas MD Anderson Cancer Center established a collaboration to develop and license new mRNA-based cancer vaccines.
Reference:
•https://www.
paho.
org/en/campaigns/world-cancer-day-2023-close-care gap#:~:text=Globally%2C%20there%20were%20an%20estimated,10%20million%20deaths%20from%20cancer.
•https://www.
reuters.
com/business/healthcare-pharmaceuticals/putin-says-russia-is-close-creatingcancer-vaccines-2024-02-14/
•https://news.
sky.
com/story/groundbreaking-lung-cancer-vaccine-being-developed-13099391
•https://www.
mskcc.
org/news/can-mrna-vaccines-fight-pancreatic-cancer-msk-clinical-researchers-are-trying-find-out
•https://www.
nihr.
ac.
uk/news/trial-begins-for-groundbreaking-new-personalised-melanoma-treatment/35928
Dr.
Khalid Mohammed Alabdulwahhab
Editor in Chief.
Related Results
Non-Recommended Publishing Lists: Strategies for Detecting Deceitful Journals
Non-Recommended Publishing Lists: Strategies for Detecting Deceitful Journals
Abstract
The rapid growth of open access publishing (OAP) has significantly improved the accessibility and dissemination of scientific knowledge. However, this expansion has also c...
PENERAPAN GAYA EDITORIAL “APA” EDISI KE-5 PADA PENULISAN ILMIAH KEPERAWATAN INDONESIA
PENERAPAN GAYA EDITORIAL “APA” EDISI KE-5 PADA PENULISAN ILMIAH KEPERAWATAN INDONESIA
AbstrakSaat penulis atau editor berbicara mengenai gaya pada tulisan ilmiah, maka yang dimaksud adalah gaya editorial, bukan gaya penulisan. Gaya editorial adalah aturan-aturan ata...
Reviewing the Reviewers Potential Financial Conflicts of Interest in Editorial Boards of Surgery Journals
Reviewing the Reviewers Potential Financial Conflicts of Interest in Editorial Boards of Surgery Journals
Objective:
To assess the prevalence, magnitude, and disclosure status of industry funding in editorial boards of surgery journals.
Sum...
Melhoria do processo editorial da Revista Fitos
Melhoria do processo editorial da Revista Fitos
O Comitê de Política Editorial da Revista Fitos, baseado em estudos e avaliações realizadas sobre os gargalos no desenvolvimento do periódico, decidiu promover alguns ajustes com v...
Editor's welcome, PORTAL, Vol. 1, No. 1, January 2004
Editor's welcome, PORTAL, Vol. 1, No. 1, January 2004
Welcome to the inaugural issue of PORTAL
On behalf of the Executive Editorial Committee of PORTAL Journal of Multidisciplinary International Studies, it is a great ple...
From Editor's Desk
From Editor's Desk
Journal of Environmental Biology is one of the leading international, interdisciplinary, open access and peer reviewed research journal that has been publishing research papers for...
Editorial Board Representation by Women in Leading Dental Journals
Editorial Board Representation by Women in Leading Dental Journals
Background: Gender imbalances persist in high-ranking leadership roles, particularly in academia. Extensive research has revealed a consistent lack of representation of individuals...
Permanencia y periodicidad
Permanencia y periodicidad
Una revista científica publicada por una sociedad de especialistas en salud brinda un aporte invaluable a la visibilización del conocimiento, porque regula y evalúa la producción c...

